<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
63323-259-30
</NDCCode>
<PackageDescription>
25 VIAL, MULTI-DOSE in 1 TRAY (63323-259-30) > 30 mL in 1 VIAL, MULTI-DOSE
</PackageDescription>
<NDC11Code>
63323-0259-30
</NDC11Code>
<ProductNDC>
63323-259
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Bacteriostatic Sodium Chloride
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Sodium Chloride
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
</RouteName>
<StartMarketingDate>
20000901
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG OTHER
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
APP Pharmaceuticals, LLC
</LabelerName>
<SubstanceName>
SODIUM CHLORIDE
</SubstanceName>
<StrengthNumber>
9
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-09-14
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20191231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>